TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
AGIO

Agios Pharmaceuticals, Inc.

Healthcare · Biotechnology

32.90$ -3.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AGIO
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -29.5% +46.9% +144.5% -14.6% +47.4% -0.8% +39.7% +3.8% -4.2% +68.6% -13.8% -24.3% +77.5% -22.0%
– -31.7% +30.4% +111.8% -6.2% +66.0% -20.5% +37.8% -0.3% +4.1% +67.2% -21.7% +0.1% +15.8% -2.4%
– -22.4% -21.6% -80.4% +2,579.1% +52.6% -1.0% +41.9% -90.0% +57.5% +59.4% -31.4% -36.7% -13.6% +16.9%
– -28.6% +30.3% +105.1% +9.9% +52.6% -1.0% +41.9% -29.9% +1.4% +78.0% -23.2% -0.8% +15.0% -4.4%
– – – +2,561.1% -8.4% -28.3% -53.8% +172.0% +46.7% +65.8% -82.8% -49.6% +27.4% +46.2% +157.4%
– – – – -5,890,500,100.0% – – – +743.6% +100.5% +10.2% -47.5% +124.6% +44.8% +19.2%
– +10.6% +5.4% +69.9% +263.6% +9.1% -3.6% -0.5% +29.4% +2.6% -10.4% -20.5% – – –
– – – – – – – – – – – – – – –
– – – – – – – – – – – – – – –
– -29.1% -25.1% -3.1% +11.0% +247.6% -8.3% -28.5% +46.4% +81.2% -67.9% -5.4% -8.6% -3.1% -14.8%
– -27.1% +5.2% +65.4% -13.4% +67.2% +7.4% -1.5% -0.7% +1.6% -36.6% +4.7% +8.5% +19.4% +1.3%
– -65.7% +22.5% +75.4% -67.2% +3,183.6% -18.5% -52.5% -88.4% +7.2% +50.6% +22.4% +9.8% +11.8% +9.6%
– -7.4% +11.2% +200.9% +33.3% +16.0% +33.1% -21.5% +22.5% -19.1% -5.8% +11.5% -47.5% +70.2% +10.3%
– – – – – – – – – – – – – – –
– -30.5% +199.5% +222.8% -18.7% +3.9% +4.7% +83.1% -6.8% -37.6% +223.4% -14.8% -26.3% +90.0% -22.6%
– – – – – – – – – – – – – – –
– +0.0% -34.1% +118.4% +11.2% +4.5% +19.1% +23.2% +4.5% +15.0% -12.4% -9.4% +1.6% +4.0% +0.1%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?